瓦尔内瓦疫苗 VALN
$5.51 −$0.13 (-2.31%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $5.51 0.00%
开盘$5.50
昨收$5.64
当日区间$5.50 – $5.64
成交量7,960
市值$524.15M
市盈率（TTM）–
股息率–
VALN 相关新闻
匹配 Valneva 或代码 VALN 的头条新闻，按最新排序。
- H.C. Wainwright Maintains Valneva(VALN.US) With Buy Rating, Maintains Target Price $18
- Valneva (VALN) Gets a Buy From H.C. Wainwright
- Guggenheim Maintains Valneva(VALN.US) With Buy Rating, Maintains Target Price $11
- TD Cowen Initiates Valneva(VALN.US) With Buy Rating, Announces Target Price $12
- Goldman Sachs Downgrades Valneva(VALN.US) to Sell Rating, Cuts Target Price to $4.9 负面
- Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO), Arcutis Biotherapeutics (ARQT) and Valneva (VALN)
- Guggenheim Maintains Valneva(VALN.US) With Buy Rating, Cuts Target Price to $11 负面
- Jefferies Maintains Valneva(VALN.US) With Buy Rating, Raises Target Price to $15 正面
- Guggenheim Maintains Valneva(VALN.US) With Buy Rating, Maintains Target Price $13
- TR | OpenAI - 4o Maintains Valneva(VALN.US) With Hold Rating, Cuts Target Price to $9.5 负面
- Jefferies Maintains Valneva(VALN.US) With Buy Rating, Cuts Target Price to $14 负面
- H.C. Wainwright Initiates Valneva(VALN.US) With Buy Rating, Announces Target Price $18
- Guggenheim Maintains Valneva(VALN.US) With Buy Rating, Cuts Target Price to $14 负面
- Guggenheim Maintains Valneva(VALN.US) With Buy Rating, Cuts Target Price to $15 负面
- H.C. Wainwright Maintains Valneva(VALN.US) With Buy Rating, Maintains Target Price $17
暂无评论——快来第一个聊聊 VALN。
登录后参与讨论。